Does Timing of Surgery Affect Rectal Cancer Outcomes? Does Timing of Surgery Affect Rectal Cancer Outcomes?
Waiting more than 12 weeks for surgery following neoadjuvant therapy was associated with improved tumor regression grade and reduced risk of systemic recurrence but not overall survival.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 14, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Episode 3: Treating Rectal Cancer: PROSPECT, PRODIGE, or OPRA? Episode 3: Treating Rectal Cancer: PROSPECT, PRODIGE, or OPRA?
Join Drs Benjamin Schlechter and Harvey Mamon as they discuss treatment options for patients with stage II and III rectal cancer based on new data from the most recent clinical trial results.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 6, 2023 Category: Consumer Health News Tags: Radiology InDiscussion Source Type: news
Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer? Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer?
Neoadjuvant chemoradiotherapy can be omitted in low-risk rectal cancer patients without compromising outcomes, but intensified in high-risk patients, new findings suggest.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 27, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
MRI Identifies Rectal Cancer Patients Who Can Skip CRT MRI Identifies Rectal Cancer Patients Who Can Skip CRT
Patients with stage I-III rectal cancer typically undergo chemoradiation before surgery, but MRI can identify those who could skip this step and go straight to upfront surgery.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 26, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Locally Recurrent Rectal Cancer QoL Is Valid Patient-Reported Outcome Measure
FRIDAY, June 9, 2023 -- A new locally recurrent rectal cancer (LRRC) quality of life (QoL) measure is a valid patient-reported outcome measure (PROM), according to a study published in the May issue of eClinicalMedicine.
Deena P. Harji, M.B.B.S.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 9, 2023 Category: Pharmaceuticals Source Type: news
ASCO: FOLFOX Noninferior to Chemoradiotherapy for Overall Survival in Rectal Cancer
FRIDAY, June 9, 2023 -- Neoadjuvant chemotherapy with fluorouracil, leucovorin, and oxaliplatin (FOLFOX) is noninferior to preoperative chemoradiotherapy with respect to overall survival for patients with locally advanced rectal cancer who are... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 9, 2023 Category: Pharmaceuticals Source Type: news
Some Cancer Patients Might Safely Skip Radiation Therapy
New clinical trials show radiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment. (Source: WebMD Health)
Source: WebMD Health - June 6, 2023 Category: Consumer Health News Source Type: news
Some Cancer Patients Might Safely Skip Radiation Therapy
New clinical trials shows radiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment. (Source: WebMD Health)
Source: WebMD Health - June 6, 2023 Category: Consumer Health News Source Type: news
Can Some Cancer Patients Safely Skip Radiation Therapy? New Studies Say Yes
TUESDAY, June 6, 2023 -- Radiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment, a pair of new clinical trials shows.
One trial found that rectal cancer patients... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 6, 2023 Category: General Medicine Source Type: news
Omitting RT Safe in Many Locally Advanced Rectal Cancers
(MedPage Today) -- CHICAGO -- Standard pelvic chemoradiotherapy prior to surgery can be safely omitted in select patients with locally advanced rectal cancer whose tumors respond to neoadjuvant chemotherapy, findings from a large cooperative... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 5, 2023 Category: Gastroenterology Source Type: news
Preoperative Treatment of Locally Advanced Rectal Cancer
(Source: Reuters: Health)
Source: Reuters: Health - June 4, 2023 Category: Consumer Health News Source Type: news
Omitting Radiation in Rectal Cancer:'Less Is More'Omitting Radiation in Rectal Cancer:'Less Is More '
Many patients with locally advanced rectal cancer can skip radiotherapy to the pelvic area, and instead be treated with chemotherapy and then surgery, suggest the results from the PROSPECT trial.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 4, 2023 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news
Rectal Cancer Patients May Not Need Radiation, Study Finds
A large “de-escalation” trial suggests that tens of thousands of people annually may be able to rely on only chemotherapy and surgery to treat their illness. (Source: NYT Health)
Source: NYT Health - June 4, 2023 Category: Consumer Health News Authors: Gina Kolata Tags: Cancer Colon and Colorectal Cancer Radiation Clinical Trials Research American Society of Clinical Oncology New England Journal of Medicine Source Type: news
ISMRM: MR radiomics interest grows, needs direction
TORONTO - Radiomics has come a long way from theory to clinical aid for MR...Read more on AuntMinnie.comRelated Reading:
Radiomics, AI model help characterize breast lesions on MRI
Can MRI radiomics help predict rectal cancer treatment response?
MRI radiomics help predict osteoarthritis knee pain improvement
fMRI radiomics, AI spot social anxiety in young adults
MRI radiomics heralds a paradigm shift in brain imaging (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 3, 2023 Category: Radiology Source Type: news
Mayo Clinic Minute: Are colon and rectal cancers treated differently?
Dr. Eric Dozois and team during a surgical procedure Colorectal cancer is a term that combines both colon cancer and rectal cancers. The colon and rectum are two different parts of the lower digestive tract. These different cancers also mean different approaches to treatment that may involve the use of radiation and chemotherapy in addition to surgery. When it comes to treating cancer, experience matters, says Dr. Eric Dozois, a Mayo Clinic colon and rectal surgeon. And Mayo… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 27, 2023 Category: Databases & Libraries Source Type: news
